SCHEMBL3800552

SCHEMBL3800552

Cc1csc([C@@H](N)Cc2c[nH]c3ccccc23)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.55
ADRB1 P08588 1/20 0.55
HTR1A P08908 1/20 0.55
ADRA2A P08913 1/20 0.55
SLC6A2 P23975 1/20 0.55
HTR1D P28221 1/20 0.55
HTR1B P28222 1/20 0.55
HTR2C P28335 1/20 0.55
HTR1E P28566 1/20 0.55
SLC6A4 P31645 1/20 0.55
HTR7 P34969 1/20 0.55
HTR2B P41595 1/20 0.55
HTR6 P50406 1/20 0.55
SLC6A3 Q01959 1/20 0.55
CYP1A2 P05177 3/20 0.51
CYP2D6 P10635 3/20 0.51
CYP2C19 P33261 3/20 0.51
CYP3A4 P08684 2/20 0.51
POLB P06746 2/20 0.51
CYP2C9 P11712 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3799963 1.00 HTR2A (0.55) HTR2AADRB1HTR1AADRA2ASLC6A2
Bromide SCHEMBL6441067 0.83 HTR2A (0.50) HTR2AADRB1HTR1AADRA2ASLC6A2
SCHEMBL27469772 0.83 SSTR1 (0.54) HTR2AADRB1HTR1AADRA2ASLC6A2
SCHEMBL27469773 0.83 SSTR1 (0.54) HTR2AADRB1HTR1AADRA2ASLC6A2
Hydrochloric Acid SCHEMBL6715553 0.82 SSTR1 (0.53) HTR2AADRB1HTR1AADRA2ASLC6A2
Hydrochloric Acid SCHEMBL27548729 0.82 SSTR1 (0.53) HTR2AADRB1HTR1AADRA2ASLC6A2
SCHEMBL27805052 0.79 POLB (0.59) CYP1A2CYP2D6CYP2C19CYP3A4POLB
SCHEMBL3792073 0.75 POLB (0.49) HTR2ACYP1A2CYP2D6CYP2C19CYP3A4
SCHEMBL3787418 0.75 POLB (0.49) HTR2ACYP1A2CYP2D6CYP2C19CYP3A4
Hydrochloric Acid SCHEMBL6715708 0.73 KDM4E (0.64) HTR2AADRB1HTR1AADRA2ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8357705-B2 Substituted cyclohexyldiamines GRUENENTHAL GMBH (DE) 2013-01-22 US disclosed
EP-2260022-A1 SUBSTITUTED CYCLOHEXYLDIAMINES Grünenthal GmbH (DE) 2010-12-15 EP disclosed
WO-2009118174-A1 SUBSTITUTED CYCLOHEXYLDIAMINES Grünenthal GmbH (DE) 2009-10-01 WO disclosed
US-20090247591-A1 SUBSTITUTED CYCLOHEXYLDIAMINES GRUNENTHAL GMBH (DE) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247591-A1 SUBSTITUTED CYCLOHEXYLDIAMINES OPRL1, OPRD1, OPRK1 HTR2A 57/4885ADRB1 27/4885HTR1A 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.